Two Sigma Investments
SGNT

Two Sigma Investments’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Two Sigma Investments’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10,006
Closed -$122K – 3460
2016
Q1 		$122K Buy
+10,006
New +$140K ﹤0.01% 2670
2015
Q3 		– Sell
-66,570
Closed -$1.62M – 3103
2015
Q2 		$1.62M Buy
+66,570
New +$1.59M 0.01% 1335
2013
Q4 		– Sell
-128,334
Closed -$2.62M – 2507
2013
Q3 		$2.62M Buy
+128,334
New +$2.86M 0.02% 708

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Two Sigma Investments's SGNT Position: Q2 2016 in Review

Two Sigma Investments sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 10,006 shares — an estimated $122K sold.

Two Sigma Investments first reported a position in SGNT in Q3 2013 and held it in 3 quarters. The position peaked at $2.62M in Q3 2013. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Two Sigma Investments reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Two Sigma Investments sold 10,006 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $122K.
  • Two Sigma Investments first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 3 quarters.
  • Two Sigma Investments's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.62M in Q3 2013.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.